What is AnaptysBio, Inc.'s net debt / EBITDA?

AnaptysBio, Inc. (ANAB) reported net debt / EBITDA of -6× in Q1 2026.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

AnaptysBio, Inc. ANAB Net debt / EBITDA

Net debt / EBITDA at other companies

Bristol-Myers SquibbBMY

2.7×-0.1×

Eli LillyLLY

1.1×-1.1×

PfizerPFE

3.8×—

AmgenAMGN

3.7×-0.7×

Regeneron PharmaceuticalsREGN

-0.1×0.0×

BiogenBIIB

1.2×+0.3×

Other financials

Income statement

See full

Revenue$25.6M-8.0%

Operating income-$34.6M-25.8%

Net income-$52.9M-34.5%

EPS (diluted)-$1.84-43.8%

Balance sheet

See full

Cash & equivalents$248.5M+152%

Total debt$13.6K-99.9%

Total equity$12.7M-62.5%

Total assets$329.7M-21.9%

Cash flow

See full

Operating cash flow-$25.9M-142%

CapEx$17.0K-51.4%

Free cash flow-$25.9M-142%

Valuation

See full

Market cap$1.73B+180%

Enterprise value$1.48B+176%

P/S7.4×+1.9×

Profitability

See full

Operating margin17.6%+9.6pp

Net margin-49.9%-22.6pp

FCF margin1.9%+1.0pp

Returns & leverage

See full

Return on equity-343.8%-1,012pp

Debt / equity0×-0.5×

Current ratio7.6×-0.7×

Where this comes from

Calculated from AnaptysBio, Inc.’s reported figures.

net debt/ebitda=-6×

Based on the most recent quarter.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AnaptysBio, Inc.'s net debt / EBITDA?: AnaptysBio, Inc. (ANAB) reported net debt / EBITDA of -6× in Q1 2026.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.